Search Result

Isoforms Recommended:	NEK7

Results for "

NEK7

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amyloid-β (2) Apoptosis (5) Autophagy (1) Caspase (4) Glutathione S-transferase (1) IDE (1) Interleukin Related (9) Ligands for E3 Ligase (1) Molecular Glues (9) NEKs (17) NF-κB (2) NOD-like Receptor (NLR) (17) PPAR (1) Pyroptosis (3) Reference Standards (1) Small Interfering RNA (siRNA) (3) STAT (1) Vasopressin Receptor (1)
By Research Areas:	Cancer (10) Cardiovascular Disease (5) Endocrinology (1) Inflammation/Immunology (19) Metabolic Disease (3) Neurological Disease (8)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N3005

Britannin 1 Publications Verification	Apoptosis Autophagy NOD-like Receptor (NLR) Pyroptosis	Inflammation/Immunology Cancer
Britannin is an NLRP3 inhibitor with an IC₅₀ of 3.630 μM, exhibiting anti-inflammatory activity. Britannin inhibits the activation and assembly of the NLRP3 inflammasome by blocking the interaction between NLRP3 and *NEK7*. Additionally, Britannin demonstrates antitumor activity by inhibiting the proliferation of tumor cells through blocking the interaction between HIF-1α and Myc, thereby suppressing PD-L1 expression and enhancing cytotoxic T lymphocyte activity. Britannin can also induce apoptosis and autophagy in liver cancer cells by activating ROS-regulated AMPK. Britannin holds promise for research in the fields of anti-inflammatory and antitumor therapeutics .

HY-176860

NEK7 degrader-1	Molecular Glues NEKs NOD-like Receptor (NLR) Caspase Interleukin Related	Cardiovascular Disease Neurological Disease Inflammation/Immunology
NEK7 degrader-1 is a NEK7 molecular glue degrader with a DC₅₀ of 9  nM. NEK7 degrader-1 dose-dependently inhibits caspase-1 activity and IL-Ιβ release in macrophages in response to NLRP3 inflammasome activation. NEK7 degrader-1 can be used for autoinflammatory and autoimmune disorders like multiple sclerosis, neurodegeneraive diseases like Alzheimer's disease and cardiovascular and melabolic disorders like pericarditis and Type 2 diabetes research .

HY-N0373

Licochalcone B 10+ Cited Publications	Amyloid-β Apoptosis NOD-like Receptor (NLR)	Neurological Disease
Licochalcone B is an extract from the root of Glycyrrhiza uralensis. Licochalcone B inhibits amyloid β (₄₂) self-aggregation (IC₅₀=2.16 μM) and disaggregate pre-formed Aβ₄₂ fibrils, reduce metal-induced Aβ₄₂ aggregation through chelating metal ionsLicochalcone B inhibits phosphorylation of NF-κB p65 in LPS signaling pathway. Licochalcone B inhibits growth and induces apoptosis of NSCLC cells. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction .

HY-159520

Ofirnoflastum Ofirnoflast; HT-6184	NEKs NOD-like Receptor (NLR) Caspase Apoptosis Pyroptosis NF-κB	Cardiovascular Disease Inflammation/Immunology Cancer
Ofirnoflastum (Ofirnoflast) is an orally active first-in-class allosteric *NEK7* inhibitor with an IC₅₀ of 46 nM. Ofirnoflastum binds an allosteric site adjacent to NEK7’s ATP-binding pocket, induces conformational shifts, disrupts NEK7-NLRP3 binding, blocks NLRP3 inflammasome assembly, spares NEK7’s physiological functions, and suppresses caspase-1, caspase-8, NF-κB, and TNF activity. Ofirnoflastum reduces pro-inflammatory cytokine production, suppresses ASC specks, IL-1β release, pyroptotic cell death, and leukemic burden, induces apoptosis and erythroid differentiation, restores hematopoiesis, and improves outcomes in colitis models. Ofirnoflastum can be used for the research of myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia .

HY-172162

LC-04-045	Molecular Glues NEKs Interleukin Related	Inflammation/Immunology Cancer
LC-04-045 is a selective NIMA-related kinase 7 (NEK7) molecular glue degrader. LC-04-045 induces NEK7 degradation via the CRBN-based ubiquitin-proteasome system, dependent on the glycine 57-containing degron motif. LC-04-045 inhibits secretion of downstream cytokines IL-1β and IL-18. LC-04-045 can be used for the research of lymphoblastic leukemia .

HY-122639

ZINC05007751 3 Publications Verification	NEKs	Cancer
ZINC05007751 is a potent NIMA-related kinase *NEK6* inhibitor with an IC₅₀ of 3.4 μM. ZINC05007751 shows antiproliferative activity against a panel of human cancer cell lines, and displays a synergistic effect with Cisplatin and Paclitaxel in a BRCA2 mutated ovarian cancer cell line. ZINC05007751 is very selective against NEK1 and NEK6 with no significant activity was observed against NEK2, NEK7, and NEK9 .

HY-W158030

2-Guanidinobezimidazole 2GBI	NOD-like Receptor (NLR) Vasopressin Receptor	Cardiovascular Disease Neurological Disease Cancer
2-Guanidinobezimidazole (2GBI) is a NLRP3 agonist with a K_D of 1.29 μM and a selective state-dependent HVCN1 blocker. 2-Guanidinobezimidazole directly binds NLRP3’s LRR domain, enhances NLRP3-ASC and *NLRP3-NEK7* interactions, and drives NLRP3 inflammasome activation. 2-Guanidinobezimidazole can be used for the research of LLC lung carcinoma, B16F10 melanoma and ischemic stroke .

HY-175452

MRT-3486	Molecular Glues Ligands for E3 Ligase NEKs	Inflammation/Immunology
MRT-3486 is a molecular glue degrader.MRT-3486 induces ternary complex formation between CRBN and predicted β-hairpin G-loop proteins.MRT-3486 is selected from an internal compound library for proximity-ligation experiments .

HY-117878

ML345 1 Publications Verification	IDE NOD-like Receptor (NLR) Interleukin Related	Inflammation/Immunology Endocrinology
ML345 is a potent and selective inhibitor of insulin-degrading enzyme (IDE) and NLRP3, with an IC₅₀ of 188 nM against IDE. ML345 targets the Cys819 residue of IDE to inhibit IDE. ML345 selectively binds to NLRP3 in a non-covalent manner. ML345 inhibits inflammatory cytokines (IL-1β, IL-6) and exhibits potent anti-inflammatory activity. ML345 exerts a protective effect against miscarriage .

HY-177433

NEK7 degrader-4	Molecular Glues NEKs	Cardiovascular Disease Neurological Disease Metabolic Disease Inflammation/Immunology
NEK7 degrader-4 is a NEK7 molecular glue degrader with a DC₅₀ of 9  nM. NEK7 degrader-4 can be used for autoinflammatory and autoimmune disorders like multiple sclerosis, neurodegeneraive diseases like Alzheimer's disease and cardiovascular and melabolic disorders like pericarditis and Type 2 diabetes research .

HY-177559

NEK7 degrader-2	NEKs Interleukin Related NOD-like Receptor (NLR)	Inflammation/Immunology
NEK7 degrader-2 (Compound 25) is a *NEK7* degrader. NEK7 degrader-2 shows dose-dependent *NEK7* degradation ability in human PBMC-derived macrophages. NEK7 degrader-2 reduce the release level of pro-inflammatory cytokines IL-1β induced by NLRP3 inflammasome activation. NEK7 degrader-2 can be used for the study of inflammatory diseases .

HY-163358

SLC3037 1 Publications Verification	NOD-like Receptor (NLR) NEKs	Cardiovascular Disease Neurological Disease Inflammation/Immunology
SLC3037 is a NLRP3 inhibitor which blocks NLRP3 from binding to *NEK7* or oligomerization, inhibiting inflammasome caused by MSU and other inflammasome activators. SLC3037 can be used for research of gout, cardiovascular diseases, metabolic syndrome or neurodegenerative diseases .

HY-173154B

NK7-902 diTFA	Molecular Glues NEKs NOD-like Receptor (NLR) Interleukin Related	Inflammation/Immunology
NK7-902 diTFA is a selective and orally active CRBN-dependent *NEK7* molecular glue degrader with K_d values of 1.5 and 2.6 μM for hNEK7 and mNEK7. NK7-902 diTFA fully degrades NEK7 in human primary monocytes and whole blood but only partially inhibits NLRP3-dependent IL-1β production. NK7-902 diTFA shows activity in murine systems and induces a profound and long-lasting NEK7 degradation but only transiently blocks NLRP3 inflammasome activation. NK7-902 diTFA can be used for the research of inflammation, such as cryopyrin-associated periodic syndromes .

HY-174270

NLRP3-IN-79	NOD-like Receptor (NLR) Interleukin Related NEKs	Inflammation/Immunology
NLRP3-IN-79 is an orally active NLRP3 inhibitor. NLRP3-IN-79 inhibits NLRP3 inflammasome with an IC₅₀ of 10.69 nM. NLRP3-IN-79 blocks NLRP3 inflammasome assembly by directly binding to NLRP3 and disrupting the *NEK7-NLRP3* interaction. NLRP3-IN-79 can be used for the study of NLRP3-driven diseases model, including systemic inflammation, peritonitis, and colitis .

HY-168737

NEK7-IN-2	NOD-like Receptor (NLR) NEKs	Inflammation/Immunology
NEK7-IN-2 (compound 23) is a potent inhibitor of *NLRP3-NEK7* interaction. NEK7-IN-2 can enhance the thermal stability of NEK7 and regulatie NLRP3 inflammasome assembly. NEK7-IN-2 inhibits IL-1β releases .

HY-169933

NEK7-IN-1	NEKs	Inflammation/Immunology Cancer
NEK7-IN-1 (Compound I-15) is the inhibitor for NIMA-related kinase 7 *NEK7* with IC₅₀ <100 nM. NEK7-IN-1 inhibits the IL-1β release with IC₅₀ <50 nM .

HY-W599279

ABS-752	Molecular Glues NEKs	Cancer
ABS-752 is a potent and orally active GSPT1 and *NEK7* molecular glue degrader. ABS-752 shows cytotoxicity. ABS-752 decreases the protein expression of GSPT1 and SALL4, NEK7. ABS-752 is a prodrug activated by the monoamine oxidase, VAP-1, to an aldehyde intermediate and subsequently to the active molecule, ABT-002 (HY-175283). ABS-752 has the potential for the research of hepatocellular carcinoma .

HY-175283

ABT-002	Molecular Glues NEKs	Cancer
ABT-002 is a molecular glue degrader targeting GSPT1 and *NEK7*. ABT-002 is the active metabolite of ABS-752 (HY-W599279). ABT-002 is promising for research of hepatocellular carcinoma (HCC) .

HY-RS09198

NEK7 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
NEK7 Human Pre-designed siRNA Set A contains three designed siRNAs for NEK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NEK7 Human Pre-designed siRNA Set A NEK7 Human Pre-designed siRNA Set A

HY-RS23673

Nek7 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Nek7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nek7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nek7 Rat Pre-designed siRNA Set A Nek7 Rat Pre-designed siRNA Set A

HY-185311

NEK7 degrader-3	Molecular Glues NEKs NOD-like Receptor (NLR) Caspase Interleukin Related Pyroptosis	Neurological Disease Inflammation/Immunology
NEK7 degrader-3 is an orally active and brain-penetrant *NEK7* molecular glue degrader with a DC₅₀ of 33.1 nM. NEK7 degrader-3 mediates interaction between NEK7 and E3 ligase cereblon, promoting proteasomal degradation of NEK7 and attenuating NLRP3 inflammasome-mediated inflammatory responses. NEK7 degrader-3 inhibits caspase-1 activity, cytokine release of IL-1β, IL-1α, and IL-18, and pyroptosis-related plasma membrane permeabilization. NEK7 degrader-3 shows antiinflammatory activity in an LPS (HY-D1056)-induced neuroinflammation mouse model. NEK7 degrader-3 can be used for the research of neuroinflammation .

HY-RS17220

Nek7 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Nek7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nek7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nek7 Mouse Pre-designed siRNA Set A Nek7 Mouse Pre-designed siRNA Set A

HY-163756

NLRP3-IN-43	NOD-like Receptor (NLR)	Inflammation/Immunology
NLRP3-IN-43 (compound II-8) is a poteny inhibitor of NLRP3 inflammasome activation that binds to the LRR domain, and disrupts *NLRP3-NEK7* interaction .

HY-N0373R

Licochalcone B (Standard)	Reference Standards Amyloid-β Apoptosis NOD-like Receptor (NLR)	Neurological Disease
Licochalcone B (Standard) is the analytical standard of Licochalcone B. This product is intended for research and analytical applications. Licochalcone B is an extract from the root of Glycyrrhiza uralensis. Licochalcone B inhibits amyloid β (42) self-aggregation (IC50=2.16 μM) and disaggregate pre-formed Aβ42 fibrils, reduce metal-induced Aβ42 aggregation through chelating metal ionsLicochalcone B inhibits phosphorylation of NF-κB p65 in LPS signaling pathway. Licochalcone B inhibits growth and induces apoptosis of NSCLC cells. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction .

HY-W998347

ABS-752 hydrochloride	Molecular Glues NEKs	Cancer
ABS-752 is an orally active prodrug of CRBN-modulating molecular glue targeting. ABS-752 can effectively degrade GSPT1. ABS-752 can degrade *NEK7*. ABS-752 does not form ternary complexes with CRBN and the neosubstrates. ABS-752 is a prodrug activated by the monoamine oxidase, VAP-1, to an aldehyde intermediate and subsequently to the active molecule, ABT-002. ABS-752 can be used for the study of hepatocellular carcinoma (HCC) .

HY-180890

PPARγ agonist-21	PPAR NF-κB NOD-like Receptor (NLR) NEKs	Metabolic Disease Inflammation/Immunology
PPARγ agonist-21 (Compound 9a) is a PPARγ agonist with an EC₅₀ of 3.12 μM. PPARγ agonist-21 activates PPAR-γ to inhibit NF-κB and attenuate NLRP3 inflammasome assembly. PPARγ agonist-21 blocks NLRP3-ASC and NLRP3-NEK7 interaction. PPARγ agonist-21 attenuates the severity of gouty arthritis .

HY-181488

NLRP3-IN-87	NOD-like Receptor (NLR) Caspase Interleukin Related	Metabolic Disease Inflammation/Immunology
NLRP3-IN-87 is a selective and orally active NLRP3 inhibitor with a K_d of 0.23 μM. NLRP3-IN-87 binds directly to the NLRP3 NACHT domain, disrupts NLRP3-NEK7 and NLRP3-ASC interactions, inhibits ASC oligomerization, and blocks inflammasome assembly. NLRP3-IN-87 suppresses caspase-1 activation and IL-1β secretion. NLRP3-IN-87 exhibits anti-inflammatory and analgesic activity, reducing joint swelling, inflammation, and pain in an MSU (HY-B2130A)-induced acute gout mouse model. NLRP3-IN-87 can be used for the research of gout .

HY-182380

ODZ10117	STAT NOD-like Receptor (NLR) Apoptosis	Others Neurological Disease Inflammation/Immunology Cancer
ODZ10117 is a STAT3 and NLRP3 inhibitor with a human STAT3 SH2 domain IC₅₀ of 7.5 μM. ODZ10117 binds to the STAT3 SH2 domain, suppressing tyrosine phosphorylation, dimerization, nuclear translocation, and transcriptional activity. ODZ10117 binds to NLRP3, impairs *NEK7* interaction, prevents inflammasome formation, and inhibits caspase-1 and IL-1β cleavage.ODZ10117 reduces MSU (HY-B2130A)-induced IL-1β release, lowers LPS (HY-D1056)-induced sepsis mortality, and exhibits anti-inflammatory effects. ODZ10117 induces apoptosis, suppresses breast cancer cell migration and invasion, reduces tumor growth and lung metastasis, and extends survival in breast cancer models. ODZ10117 can be used for the research of Monosodium urate (HY-B2130A)-induced peritonitis, LPS-induced sepsis, breast cancer, glioblastoma, and Alzheimer's disease .

HY-179635

GSTO1-IN-6	Glutathione S-transferase Interleukin Related	Inflammation/Immunology
GSTO1-IN-6 is an allosteric and covalent GSTO1 inhibitor with an IC₅₀ of 457 nM. GSTO1-IN-6 markedly reduces Lipopolysaccharides (LPS) (HY-D1056)-induced IL-1β (IC₅₀ of 1.9 μM) and IL-18 (IC₅₀ of 10. μM) secretion in human monocyte-derived macrophages. GSTO1-IN-6 covalently modifies GSTO1-Cys32, inducing conformational changes and protein destabilization. GSTO1-IN-6 can be used for the research of inflammatory diseases .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N3005

Britannin 1 Publications Verification	Phyllodium pulchellum (L.) Desv. Classification of Application Fields Terpenoids Sesquiterpenes Plants Compositae Inflammation/Immunology Disease Research Fields Source Classification	Apoptosis Autophagy NOD-like Receptor (NLR) Pyroptosis
Britannin is an NLRP3 inhibitor with an IC₅₀ of 3.630 μM, exhibiting anti-inflammatory activity. Britannin inhibits the activation and assembly of the NLRP3 inflammasome by blocking the interaction between NLRP3 and *NEK7*. Additionally, Britannin demonstrates antitumor activity by inhibiting the proliferation of tumor cells through blocking the interaction between HIF-1α and Myc, thereby suppressing PD-L1 expression and enhancing cytotoxic T lymphocyte activity. Britannin can also induce apoptosis and autophagy in liver cancer cells by activating ROS-regulated AMPK. Britannin holds promise for research in the fields of anti-inflammatory and antitumor therapeutics .

HY-N0373

Licochalcone B 10+ Cited Publications	Chalcones Flavonoids Leguminosae Plants Glycyrrhiza uralensis Fisch. Source Classification	Amyloid-β Apoptosis NOD-like Receptor (NLR)
Licochalcone B is an extract from the root of Glycyrrhiza uralensis. Licochalcone B inhibits amyloid β (₄₂) self-aggregation (IC₅₀=2.16 μM) and disaggregate pre-formed Aβ₄₂ fibrils, reduce metal-induced Aβ₄₂ aggregation through chelating metal ionsLicochalcone B inhibits phosphorylation of NF-κB p65 in LPS signaling pathway. Licochalcone B inhibits growth and induces apoptosis of NSCLC cells. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction .

HY-N0373R

Licochalcone B (Standard)	Structural Classification Chalcones Flavonoids Leguminosae Phenols Polyphenols Plants Glycyrrhiza uralensis Fisch. Source Classification	Reference Standards Amyloid-β Apoptosis NOD-like Receptor (NLR)
Licochalcone B (Standard) is the analytical standard of Licochalcone B. This product is intended for research and analytical applications. Licochalcone B is an extract from the root of Glycyrrhiza uralensis. Licochalcone B inhibits amyloid β (42) self-aggregation (IC50=2.16 μM) and disaggregate pre-formed Aβ42 fibrils, reduce metal-induced Aβ42 aggregation through chelating metal ionsLicochalcone B inhibits phosphorylation of NF-κB p65 in LPS signaling pathway. Licochalcone B inhibits growth and induces apoptosis of NSCLC cells. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction .

Recombinant Proteins Recommended:

NEK7

Species:	Human (4)
Tag:	SUMO (1) His (4) GST (2)
Source:	Sf9 insect cells (2) E. coli (2)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P702740

	NEK7 Protein, Human (His) NEK7; NIMA related kinase 7	Human	E. coli
	The NEK7 protein is a key kinase that crucially drives mitotic cell cycle progression by enhancing centrosomal microtubule nucleation, ensuring robust spindle formation, and aiding in cytokinesis. Phosphorylation of EML4 at “Ser-146” promotes chromosome aggregation. NEK7 Protein, Human (His) is the recombinant human-derived NEK7, expressed by E. coli, with His labeled tag.

HY-P701253

	NEK7 Protein, Human (His-SUMO) Serine/threonine-protein kinase NEK7; NimA-related protein kinase 7; NEK7	Human	E. coli
	The NEK7 protein is a key kinase that crucially drives mitotic cell cycle progression by enhancing centrosomal microtubule nucleation, ensuring robust spindle formation, and aiding in cytokinesis. Phosphorylation of EML4 at “Ser-146” promotes chromosome aggregation. NEK7 Protein, Human (His-SUMO) is the recombinant human-derived NEK7 protein, expressed by E. coli , with N-6*His-SUMO labeled tag.

HY-P75935

	NEK7 Protein, Human (Inactive, sf9, His-GST) 1 Publications Verification Serine/threonine-protein kinase NEK7; NimA-related protein kinase 7; NEK7	Human	Sf9 insect cells
	The NEK7 protein is a key kinase that crucially drives mitotic cell cycle progression by enhancing centrosomal microtubule nucleation, ensuring robust spindle formation, and aiding in cytokinesis. Phosphorylation of EML4 at “Ser-146” promotes chromosome aggregation. NEK7 Protein, Human (sf9, His-GST) is the recombinant human-derived NEK7 protein, expressed by Sf9 insect cells , with N-His, N-GST labeled tag.

HY-P706078

	NEK7 Protein, Human (Active, sf9, His-GST) Serine/threonine-protein kinase NEK7; Never in mitosis A-related kinase 7; NimA-related protein kinase 7	Human	Sf9 insect cells

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Rabbit (3)
Reactivity:	Human (1) Rat (3) Mouse (3)
Application:	IHC-P (1) ICC/IF (1) IP (2) WB (3) FC (1)
Isotype:	IgG (3)
Conjugation:	Non-conjugated (3)
Clonality:	Monoclonal (2) Recombinant (2)
Modification:	Unmodified (2)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81615

	NEK7 Antibody (YA1360) NEK7; NimA related protein kinase 7	WB, IP	Mouse, Rat
	NEK7 Antibody (YA1360) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NEK7.

HY-P81615A

	NEK7 Antibody (YA1360)(PBS only) NEK7; NimA related protein kinase 7	WB, IP	Mouse, Rat
	NEK7 Antibody (YA1360) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to NEK7.

HY-P810426

	NEK7 Antibody (YA9739) EC 2.7.11.1, NEK7, NEK7_HUMAN, Never in mitosis A-related kinase 7, Never in mitosis gene a-related kinase 7, NIMA (never in mitosis gene a) related kinase 7, NIMA (never in mitosis gene a)-related expressed kinase 7, NimA related protein kinase 7, NIMA-related kinase 7, NimA-related protein kinase 7	WB, IHC-P, FC, ICC/IF	Human, Mouse, Rat
	NEK7 Antibody (YA9739) is a Rabbit-derived and non-conjugated IgG Recombinant,Monoclonal antibody, targeting to NEK7.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks